Skip to main content
SpringerLink
Log in

Drug-Induced Changes to Nutritional Status

  • Chapter
Handbook of Drug-Nutrient Interactions

Part of the book series: Nutrition and Health ((NH))

Abstract

Drug-induced changes to nutritional status may be a direct or indirect consequence of the drug or chemical. Medications may affect the patient’s nutritional status by altering body weight, altering taste perception (thereby decreasing intake), altering macronutrient metabolism, decreasing nutrient absorption, or depleting essential vitamins and minerals. Either by the drug’s mechanism of action or by its adverse effects, patient’s nutritional status may be affected. Recognizing and acknowledging drug-induced changes to nutritional status is imperative for optimal patient care.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Umbricht D, Kane J. Medical complications of new antipsychotic drugs. Schizophrenia Bulletin 1996; 22: 475–483.

    Article  CAS  Google Scholar 

  2. Kusumakar V. Antidepressants and antipsychotics in the long-term treatment of bipolar disorder. J Clin Psychiatry 2002; 63 (suppl 10): 23–28.

    CAS  Google Scholar 

  3. Vanina Y, Podalskaya A, Sedky K et al. Body weight changes associated with psychopharmacology. Psychiatric Services 2002; 53: 842–847.

    Article  Google Scholar 

  4. Pischon T, Sharma AM. Use of beta-blockers in obesity hypertension: potential role of weight gain. Obes Rev 2001; 2: 275–280.

    Article  CAS  Google Scholar 

  5. ESHRE Capri Workshop Group. Continuation rates of oral contraceptives and hormone replacement therapy. Human Reproduction 2000; 15: 1865–1871.

    Article  Google Scholar 

  6. James J. Marijuana safety study completed: weight gain, no safety problems. AIDS Treat News 2000; 348: 3–4.

    Google Scholar 

  7. Mulligan K, Schambelan M. Anabolic treatment with GH, IGF-1, or anabolic steroids in patients with HIV-associated wasting. Int J Cardiol 2002; 85: 151–159.

    Article  Google Scholar 

  8. Coney P, Washenik K, Langley RG, DiGiovanna JJ, Harrison DD. Weight change and adverse event incidence with low-dose oral contraceptive: two randomized, placebo-controlled trials. Contraception 2001; 63: 297–302.

    Article  CAS  Google Scholar 

  9. Davies KM, Heaney RP, Recker RR, Barger-Lux MJ, Lappe JM. Hormones, weight change and menopause. Int J Obes Relat Metab Disord 2001; 25: 874–879.

    Article  CAS  Google Scholar 

  10. Golinko BE. Side effect of dextroamphetamine and methylphenidate in hyperactive children-a brief review. Prog Neuropsychopharmacol Biol Psychiatry 1984; 8: 1–8.

    Article  CAS  Google Scholar 

  11. Perkins KA, Sexton JE, DiMarco A. Acute thermogenic effects of nicotine and alcohol in healthy male and female smokers. Physiol Behav 1996; 60: 305–309.

    Article  CAS  Google Scholar 

  12. Safer DJ, Allen RP, Barr E. Growth rebound after termination of stimulant drugs. J Pediatr 1975; 86 (1): 113–116.

    Article  CAS  Google Scholar 

  13. Huffman GB. Evaluating and treating unintentional weight loss in the elderly. Am Fam Physician 2002; 65: 640–650.

    Google Scholar 

  14. Markley EJ, Mattes-Kulig DA, Henkin RI. A classification of dysgeusia. J Am Diet Assoc 1998; 83: 578–580.

    Google Scholar 

  15. Ackerman BH, Kasbekar N. Disturances of taste and smell induced by drugs. Pharmacotherapy 1997; 17: 482–496.

    CAS  Google Scholar 

  16. Bartoshuk LM, Beauchamp GK. Chemical senses. Annu Rev Psychol 1994; 45: 419–449.

    Article  CAS  Google Scholar 

  17. Micromedex Healthcare Series. Available at: http://healthcare.micromedex.com

    Google Scholar 

  18. Mott AE, Leopold DA. Disorders of taste and smell. Med Clin North Am 1991; 75: 13231–13253.

    Google Scholar 

  19. Davies AN, Daniels C, Pugh R et al. A comparison of artificial saliva and pilocarpine in the management of xerostomia in patients with advanced cancer. Palliat Med 1998; 12: 105–111.

    Article  CAS  Google Scholar 

  20. Soderling E, Le Bell A, Krstila V et al. Betaine-containing toothpaste relieves subjective symptoms of dry mouth. Acta Odontol Scand 1998; 56: 65–69.

    Article  CAS  Google Scholar 

  21. Henkin RI, Schecter PJ, Friedewald WT, Demets DL, Raff M. A double blind study of the effects of zinc sulfate on taste and smell dysfunction. Am J Med Sci 1976; 272: 285–299.

    Article  CAS  Google Scholar 

  22. Souder E, Yoder L. Olfaction: the neglected sense. J Neurosci Nurs 1992; 24: 273–280.

    Article  CAS  Google Scholar 

  23. Taylor AT. Nausea and vomiting. In: DiPiro JT, ed. Pharmacotherapy: A Pathophysiologic Approach, ed 5. McGraw-Hill, New York, 2002, pp. 641–653.

    Google Scholar 

  24. Rollins CJ. General pharmacologic issues. In: Matarese LE, ed. Contemporary Nutrition Support Practice: A Clinical Guide. W.B. Saunders, Philadelphia, PA, 1998, pp. 303–332.

    Google Scholar 

  25. Foss JF. A review of the potential role of methylnaltrexone in opioid bowel dysfunction. Am J Surg 2001; 182: 19S–26S.

    Article  CAS  Google Scholar 

  26. Taguchi A, Sharma N, Saleem RM, et al. Selective postoperative inhibition of gastrointestinal opioid receptors. N Engl J Med 2001; 345: 935–940.

    Article  CAS  Google Scholar 

  27. Mills GA, Horn JR. Beta-blockers and glucose control. Drug Intell Clini Pharm 1985; 19: 246–251.

    CAS  Google Scholar 

  28. Skouby SO. Oral contraceptives: hormonal dose and effects on carbohydrate metabolism. Maturitas 1988; 1 (suppl): 111–115.

    Article  Google Scholar 

  29. Luna B, Feinglos MN. Drug induced hypoglycemia. JAMA 2001; 286 (16): 1945–1948.

    Article  CAS  Google Scholar 

  30. Van Hooff JP, Christiaans MH. Use of tacrolimus in renal transplantation. Transplant Proc 1999; 31: 3298–3299.

    Article  Google Scholar 

  31. American Association of Diabetes Educators. A Core Curriculum for Diabetes Education (3rd ed, Vol 10), Chicago, IL, 1998, pp. 338–341.

    Google Scholar 

  32. Marks V, Teale JD. Drug-induced hypoglycemia. Endocrinol Metab Clin North Am 1999; 28: 555–577.

    Article  CAS  Google Scholar 

  33. Bunout D. Nutritional and metabolic effects of alcoholism: their relationship with alcoholic liver disease. Nutrition 1999; 15: 583–589.

    Article  CAS  Google Scholar 

  34. Chan JC, Cockram CS, Critchley JA. Drug-induced disorders of glucose metabolism. Mechanisms and management. Drug Saf 1996; 15: 135–157.

    Article  CAS  Google Scholar 

  35. Mantel-Teeuwisse AK, Kloosterman JM, Maitland-van der Zee AH, Klungel OH, Porsius AJ, de Boer A. Drug-induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels. Drug Saf 2001; 24: 443–456.

    Article  CAS  Google Scholar 

  36. Strobl JS, Thomas MJ. Human growth hormone. Pharmacol Rev 1994; 46: 1–34.

    CAS  Google Scholar 

  37. Kupfer SR, Underwood LE, Baxter RC, et al. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor-1 by use of both agents simultaneously. J Clin Invest 1993; 91; 391–396.

    Article  CAS  Google Scholar 

  38. Hausmann DF, Nutz V, Rommelsheim K, et al. Anabolic steroids in polytrauma patients. Influence on renal nitrogen and amino acid losses: a double blind study. J Parent Enter Nutr 1990; 14: 111–114.

    Article  CAS  Google Scholar 

  39. Hansel DT, Davies JWL, Shenkin A, et al. The effects of an anabolic steroid and peripherally administered intravenous nutrition in the early postoperative period. J Parent Enter Nutr 1989; 13: 349–357.

    Article  Google Scholar 

  40. Demling RH, DeSanti L. Oxandrolone, an anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns. J Trauma 1997; 43: 47–51.

    Article  CAS  Google Scholar 

  41. Hengge UR, Baumann M, Maleba R, et al. Oxymetholone promotes weight gain in patients with advanced human immunodefiency virus (HIV-1) infection. Sr J Nutr 1996; 75: 129–138

    Article  CAS  Google Scholar 

  42. Wolthers OD. Inhaled corticosteroids and growth. J Pediatr Endocrinol Metab 2001; 14: 1487–1490.

    Google Scholar 

  43. Pelton R, LaValle JB, Hawkins EB, Krinsky DL (eds.). Drug-Induced Nutrient Depletion Handbook ( 2nd ed ). Lexi-Comp Inc, Hudson, OH, 2001.

    Google Scholar 

Download references

Authors
  1. Jane M. Gervasio
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pharmacy Practice, Temple University School of Pharmacy, Philadelphia, PA, USA

    Joseph I. Boullata PharmD, BCNSP

  2. Department of Surgery, Temple University School of Medicine, Philadelphia, PA, USA

    Vincent T. Armenti MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gervasio, J.M. (2004). Drug-Induced Changes to Nutritional Status. In: Boullata, J.I., Armenti, V.T. (eds) Handbook of Drug-Nutrient Interactions. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-781-9_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-781-9_13

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-5359-2

  • Online ISBN: 978-1-59259-781-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation